Revolution Medicines Shares Fall After Incyte Cancer Data
Revolution Medicines shares fell after Incyte posted pancreatic cancer data described as competitive.
Story updates
04:07:07 PM UTC
SquawkNews
BUZZ-Incyte公布具竞争力的胰腺癌数据后 Revolution Medicines股价下跌 10月26日 - ** Revolution Medicines(RVMD.O)股价下跌1%,报18